Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 45Leukemia 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Leukemia, Erythroblastic, Acute 14Leukemia, Myelomonocytic, Acute 13Leukemia, Monocytic, Acute 13Leukemia, Megakaryoblastic, Acute 13Congenital Abnormalities 11Myelodysplastic Syndromes 8Lymphoma 7Burkitt Lymphoma 7Anemia, Refractory, with Excess of Blasts 7Leukemia, Eosinophilic, Acute 5Myeloproliferative Disorders 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Biphenotypic, Acute 4Leukemia, Basophilic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic-Myeloproliferative Diseases 3Neoplasm Metastasis 2Leukemia, Promyelocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Down Syndrome 2Anemia, Refractory 2Sarcoma, Myeloid 1Sarcoma, Kaposi 1Sarcoma 1Recurrence 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1

Interventions

Doxorubicin 6Vincristine 4Liposomes 4Bleomycin 4Fluorouracil 2sargramostim 1liposomal doxorubicin 1Zidovudine 1Watchful Waiting 1Radiotherapy 1Paclitaxel 1Observation 1Methotrexate 1Light Coagulation 1Leucovorin 1Laser Therapy 1Isotretinoin 1Imiquimod 1Dexamethasone 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Acquired Immunodeficiency Syndrome × Daunorubicin × Clear all
NCT00002093 2005-06-24

A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma.

NIH AIDS Clinical Trials Information Service

Phase 3 Completed
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡